Welcome to Dwaey, specifically on Isoniazid + Thiacetazone page.
This medicine contains important and useful components, as it consists of
Isoniazid + Thiacetazone is available in the market in concentration.
Isoniazid + Thiacetazone
Before starting isoniazid and thiacetazone, it is crucial for patients to consult their healthcare provider to ensure the safe and appropriate use of these medications. Important precautions include:
- Liver Disease: Both isoniazid and thiacetazone can cause hepatotoxicity. Liver function tests should be conducted before and during treatment. Patients with pre-existing liver disease or a history of liver dysfunction should be monitored more closely.
- Peripheral Neuropathy: Isoniazid can cause peripheral neuropathy, leading to symptoms like tingling, numbness, or pain in the hands and feet. Vitamin B6 supplementation is often recommended to prevent or treat this side effect.
- Hematological Monitoring: Thiacetazone can cause blood disorders, including agranulocytosis (low white blood cell count) and anemia. Regular blood tests should be done to monitor for these effects.
- Alcohol Consumption: Alcohol should be avoided during treatment, as it can exacerbate liver toxicity and increase the risk of severe side effects.
- Pregnancy and Breastfeeding: Thiacetazone is not recommended during pregnancy or breastfeeding due to the potential for harm to the fetus or infant. It should only be used if the benefits outweigh the risks and under strict medical supervision.
- Renal Impairment: Patients with renal impairment should use thiacetazone with caution, as it may further compromise kidney function. Monitoring of kidney function is advised during treatment.
Isoniazid and thiacetazone are used in the treatment of tuberculosis (TB), particularly when first-line agents such as rifampicin and isoniazid alone are not effective or available. This combination is indicated for:
- Active Tuberculosis: Isoniazid and thiacetazone are used in the treatment of active TB, particularly in areas where multidrug-resistant TB (MDR-TB) is prevalent or when other therapies are not suitable.
- Latent Tuberculosis: Isoniazid is often used alone or with thiacetazone in cases of latent tuberculosis to prevent the progression to active disease, though thiacetazone is not routinely used in this context.
This combination is generally used in specific cases, particularly for patients with multidrug-resistant TB or when there are concerns about treatment failure with first-line TB medications.
The combination of isoniazid and thiacetazone should not be used in certain conditions, including:
- Severe Liver Disease: Both drugs can lead to liver damage, so they should not be used in patients with active liver disease or those with significant liver dysfunction, such as hepatitis or cirrhosis.
- Hypersensitivity: Patients with known hypersensitivity to isoniazid, thiacetazone, or any other components of the medications should avoid this treatment.
- Severe Renal Impairment: Isoniazid and thiacetazone should be used with caution in patients with severe renal impairment, and close monitoring of kidney function is necessary.
- Pregnancy and Breastfeeding: Thiacetazone is contraindicated during pregnancy and breastfeeding, as it poses a risk to the fetus or infant. Isoniazid may be used during pregnancy under strict supervision, but thiacetazone should be avoided.
The combination of isoniazid and thiacetazone can lead to various side effects, ranging from mild to severe. Patients should be aware of the following:
- Common Side Effects:
- Gastrointestinal Symptoms: Nausea, vomiting, abdominal discomfort, and loss of appetite.
- Fatigue: General tiredness and weakness are commonly reported during treatment.
- Rash: Mild skin rashes can occur, particularly with thiacetazone.
- Serious Side Effects:
- Liver Toxicity: Both isoniazid and thiacetazone can cause liver damage, with symptoms such as jaundice, dark urine, and fatigue. Liver function tests should be monitored regularly.
- Peripheral Neuropathy: Isoniazid is associated with the risk of peripheral neuropathy (numbness, tingling, or pain in the extremities). Vitamin B6 supplementation is recommended to reduce this risk.
- Blood Disorders: Thiacetazone can cause serious blood disorders, including agranulocytosis (a decrease in white blood cells), anemia, and thrombocytopenia (low platelet count), requiring regular blood tests.
- Hypersensitivity Reactions: Rarely, an allergic reaction to either drug may cause swelling, difficulty breathing, and severe rash. Immediate medical attention is required in such cases.
3
Isoniazid and thiacetazone work through different mechanisms to treat *Mycobacterium tuberculosis*:
- Isoniazid: Isoniazid inhibits the synthesis of mycolic acids, an essential component of the bacterial cell wall. This weakens the bacterial cell wall, leading to bacterial death, especially in actively dividing bacteria.
- Thiacetazone: Thiacetazone works by interfering with the metabolic processes in the *Mycobacterium tuberculosis* bacteria. It inhibits the synthesis of proteins and nucleic acids in the bacteria, thereby preventing their growth and replication.
The combined effects of these drugs provide a more potent treatment regimen, particularly in cases where multidrug-resistant TB is present or where first-line drugs are ineffective.
Isoniazid and thiacetazone can interact with other drugs, potentially affecting their efficacy or safety. Some important drug interactions include:
- Alcohol: Both isoniazid and thiacetazone can increase the risk of liver damage when combined with alcohol. Patients should avoid alcohol consumption during treatment.
- Phenytoin (Antiepileptics): Isoniazid can increase the levels of phenytoin in the blood, leading to potential toxicity. Close monitoring and dose adjustment may be required.
- Anticoagulants (e.g., Warfarin): Isoniazid may enhance the effects of warfarin, increasing the risk of bleeding. INR (international normalized ratio) should be monitored, and warfarin doses may need adjustment.
- Rifampicin: Rifampicin can induce the metabolism of isoniazid and thiacetazone, potentially reducing their efficacy. Close monitoring is advised when these drugs are used together.
- Other Hepatotoxic Drugs: Combining isoniazid and thiacetazone with other medications that have hepatotoxic potential (e.g., certain antifungals, antiretrovirals) increases the risk of liver damage.
The standard dose for adult patients is:
- Isoniazid: 5 mg/kg body weight daily (up to a maximum of 300 mg/day).
- Thiacetazone: 150 mg daily.
This combination is typically administered for the intensive phase of TB treatment (usually the first two months), after which the regimen may be adjusted.
For pediatric patients, the dosing is based on the child’s weight:
- Isoniazid: 10 mg/kg body weight daily (maximum 300 mg/day).
- Thiacetazone: 75-100 mg daily, depending on weight and clinical response.
Pediatric dosing should be done under the guidance of a healthcare provider, and the child should be monitored for any side effects during treatment.
---
As always, patients should consult their healthcare provider before starting this combination therapy to ensure it is appropriate for their condition and to discuss potential risks or drug interactions. Regular monitoring of liver function, blood counts, and overall health is essential during treatment.
For patients with renal impairment, dose adjustments may be required, especially if the patient has severe renal dysfunction:
- Mild to Moderate Renal Impairment: No major adjustments are generally needed, but renal function should be closely monitored.
- Severe Renal Impairment: The use of thiacetazone should be approached with caution, and dose reductions may be required based on renal function tests.
Not available in a medicine form yet